Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against RxSight, Inc. (RXST)

Core Viewpoint - A securities class action lawsuit has been filed against RxSight, Inc. for failing to disclose significant operational challenges and misleading investors regarding the company's financial outlook [1][2]. Group 1: Allegations Against the Company - The lawsuit alleges that RxSight faced "adoption challenges" and structural issues leading to declines in sales and utilization [2]. - It is claimed that the company overstated the demand for its products, which contributed to an inability to meet previously issued financial guidance for fiscal year 2025 [2]. - The positive statements made by the company regarding its business operations and prospects were deemed materially misleading and lacked a reasonable basis [2]. Group 2: Financial Impact - On July 8, 2025, RxSight reported preliminary second quarter 2025 financial results, indicating significant declines in LDD sales, LAL utilization, and overall revenue [3]. - Following this announcement, the company's stock price dropped by $4.84, or 37.8%, closing at $7.95 per share on July 9, 2025, with unusually heavy trading volume [3].